Mark Cobbold
Impact in
- Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Epidemiology top 1%
- Cytomegalovirus and herpesvirus research
- Herpesvirus Infections and Treatments
Papers in
- Immunology 30
- Immune Cell Function and Interaction 13
- Immunotherapy and Immune Responses 11
- T-cell and B-cell Immunology 8
- Oncology 18
- CAR-T cell therapy research 11
- Cancer Immunotherapy and Biomarkers 6
- Co-authors
- Paul Moss (14 shared papers)Naeem Khan (8 shared papers)Laxman Nayak (2 shared papers)Rachel Bruton (3 shared papers)Alan J. Sinclair (1 shared paper)Charles Craddock (5 shared papers)John M. Goldman (3 shared papers)Russell Keenan (2 shared papers)
- Journals
- Blood (5 papers)The Journal of Immunology (4 papers)Cancer Research (4 papers)Journal of Immunological Methods (3 papers)European Journal of Immunology (2 papers)
- Partner nations
- United KingdomUnited StatesGermany
In The Last Decade
Mark Cobbold
54 papers receiving 2.9k citations
Mark Cobbold's Hit Papers
Peers
Comparison fields: 5 of 99
- Immunology 1.4k
- Epidemiology 1.3k
- Oncology 724
- Transplantation 56
- Virology 97
Countries citing papers authored by Mark Cobbold
This map shows the geographic impact of Mark Cobbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Cobbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Cobbold more than expected).
Fields of papers citing papers by Mark Cobbold
This network shows the impact of papers produced by Mark Cobbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Cobbold. The network helps show where Mark Cobbold may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Cobbold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cytomegalovirus Seropositivity Drives the CD8 T Cell Repertoire Toward Greater Clonality in Healthy Elderly Individuals Hit paper breakdown → | 2002 | 571 |
| 2 | 2005 | 392 | |
| 3 | Dual Programmed Death Receptor‐1 and Vascular Endothelial Growth Factor Receptor‐2 Blockade Promotes Vascular Normalization and Enhances Antitumor Immune Responses in Hepatocellular Carcinoma Hit paper breakdown → | 2019 | 315 |
| 4 | 2004 | 269 | |
| 5 | 2001 | 239 | |
| 6 | 2002 | 152 | |
| 7 | 2008 | 121 | |
| 8 | 2017 | 113 | |
| 9 | 2015 | 67 | |
| 10 | 2002 | 63 | |
| 11 | 2001 | 52 | |
| 12 | 2014 | 44 | |
| 13 | 2017 | 39 | |
| 14 | 2005 | 38 | |
| 15 | 2020 | 37 | |
| 16 | 2013 | 36 | |
| 17 | 2009 | 33 | |
| 18 | 2016 | 31 | |
| 19 | 2006 | 31 | |
| 20 | 2018 | 27 |
About Mark Cobbold
Mark Cobbold is a scholar working on Immunology, Oncology, Epidemiology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 59 papers that have together received 3.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (13 papers), Cytomegalovirus and herpesvirus research (13 papers), CAR-T cell therapy research (11 papers), Immunotherapy and Immune Responses (11 papers), T-cell and B-cell Immunology (8 papers), Herpesvirus Infections and Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Immunology (1.4k citations), Epidemiology (1.3k citations), Oncology (724 citations), Transplantation (56 citations) and Virology (97 citations). Mark Cobbold has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Paul Moss, Naeem Khan, Laxman Nayak, Rachel Bruton, Alan J. Sinclair, Charles Craddock, John M. Goldman, Russell Keenan, Alan B. Rickinson and Andrew D. Hislop. Their work appears in journals such as Blood, The Journal of Immunology, Cancer Research, Journal of Immunological Methods and European Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.